FDA Approves First Tumor-infiltrating Lymphocyte Therapy
The FDA has granted accelerated approval to lifileucel, a new type of cell therapy, for the treatment of melanoma....
Progress Against Cancer
The FDA has granted accelerated approval to lifileucel, a new type of cell therapy, for the treatment of melanoma....
The FDA has granted full approval to tepotinib for some non-small cell lung cancers that harbor a certain mutation...
The FDA has approved irinotecan liposome plus chemotherapy for the first-line treatment of metastatic pancreatic cancer. The U.S. Food...
The FDA has approved the FGFR inhibitor erdafitinib for certain patients with urothelial carcinoma The U.S. Food and Drug...
The FDA expanded the indications for pembrolizumab to include more patients with stage III-IVA cervical cancer. The U.S. Food...
Enfortumab vedotin-ejfv plus pembrolizumab was approved for certain bladder cancers. The U.S. Food and Drug Administration (FDA) has approved...
Belzutifan is now available for certain patients with kidney cancer whether or not they have von Hippel-Lindau disease. The...
The FDA has approved eflornithine to prevent relapse after standard-of-care therapy for neuroblastoma. The U.S. Food and Drug Administration...
The FDA has approved pirtobrutinib for patients with heavily pretreated chronic lymphocytic leukemia or small lymphocytic lymphoma. The U.S....
The FDA has approved nirogacestat for the treatment of noncancerous but painful growths called desmoid tumors. The U.S. Food...